BIOMAT Database Logo BIOMAT Database Logo

Graft failure due to hemolytic uremic syndrome recurrence. 2006

G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Clinica Chirurgica Università Tor Vergata, Ospedale S.Eugenio Roma.

The hemolytic uremic syndrome (HUS) is a severe disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. We herein report our experience with a 43-year-old female patient who underwent a second cadaveric kidney transplantation in February 2005, for adult-onset HUS. The first renal transplantation, which was performed in 1996, required removal after 3 weeks for probable recurrence of HUS. The immunosuppressive regimen for the second transplant included basiliximab, tacrolimus, mycophenolate mofetil, and steroids. On postoperative day (POD) 7, she received steroid treatment for an acute rejection episode with improved renal function. On POD 19 due to worsening renal function, a graft biopsy showed HUS recurrence, thus we instituted hemodialysis and then plasmapheresis treatments. At two months after transplantation, the patient continued under plasmapheresis treatment due to clinical evidence of HUS. On POD 80, cytomegalovirus infection was diagnosed and intravenous gancyclovir treatment started for 3 weeks. After 110 days from transplant, a deterioration in renal function was evident: the graft was swollen and painful with Doppler ultrasound showing patency of both the renal artery and vein but, low blood flow. After 2 weeks of hemodialysis, the patient underwent transplantectomy. In adult-onset HUS the recurrence rate reduces graft survival, particularly among patients undergoing second transplantation.

UI MeSH Term Description Entries
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Late renal trnsplant failure due to the hemolytic-uremic syndrome.
May 1971, Acta medica Scandinavica,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Acute renal failure due to hemolytic uremic syndrome in adult patients.
March 1997, Renal failure,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Unexpected childhood death due to hemolytic uremic syndrome.
March 2000, The American journal of forensic medicine and pathology,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Hemolytic uremic syndrome recurrence after renal transplantation.
September 2008, Pediatric transplantation,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Posttransplant recurrence of atypical hemolytic uremic syndrome.
January 2012, Journal of nephrology,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
The radiology of enteritis due to hemolytic-uremic syndrome.
January 1982, Pediatric radiology,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Atypical hemolytic uremic syndrome due to factor H autoantibody.
January 2013, The Turkish journal of pediatrics,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Hemolytic uremic syndrome due to homozygous factor H deficiency.
October 2009, Clinical and experimental nephrology,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Recurrence of hemolytic uremic syndrome after renal transplantation.
October 2007, Transplantation proceedings,
G Iaria, and B Iorio, and A Anselmo, and L De Luca, and L Tariciotti, and B Ielpo, and F Muzi, and C Lucchesi, and D D'Andria, and G Orlando, and G Del Poeta, and E Poggi, and A Piazza, and G Tisone
Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
December 2014, Transplantation,
Copied contents to your clipboard!